1407 GMT - Reckitt Benckiser investors are likely to focus on 2025 outlook as nothing major happened since the last earnings, Barclays analysts say in a note. The U.K. consumer-goods company is expected to provide 2025 guidance of 3% to 5% organic sales growth for its core business, which excludes essential home and Mead Johnson, they say. However, Reckitt could also issue a conservative target given the limited visibility, and volatility due to flu and retailer inventory dynamics, the analysts add. They warn, however, that almost every global health and personal care products company warned of an unusually weak 1Q, meaning the health segment could face pressures. Reckitt reports its 2024 results on Thursday. Shares are up 0.3% at 52.54 pounds. (michael.susin@wsj.com)
(END) Dow Jones Newswires
March 03, 2025 09:08 ET (14:08 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.